[dr Deana B. Andric]

Hemijski fakultet, Studentski trg 12-16, Beograd
Katedra za organsku hemiju

Telefon:   011-3336759

Telefon (lokalni):   759

Kabinet:   476

Laboratorija:   463

E-mail:   deanad@chem.bg.ac.rs

Lični podaci

Datum i mesto rođenja: 20. 1. 1963, Beograd. Udata. Jezici koje koristi: srpski (maternji) i engleski.

Obrazovanje i usavršavanja

1981-1987: Osnovne studije - Hemijske nauke / Prirodno-matematički fakultet (Beograd)

1987-1991: Magistratura - Hemijske nauke / Univerzitet u Beogradu - Hemijski fakultet (Beograd)

1992-1996: Doktorat - Hemijske nauke / Univerzitet u Beogradu - Hemijski fakultet (Beograd)

Kretanje u službi

1989-1991: Saradnik i nastavi / IHTM (Beograd)

1991-1999: Asistent / Veterinarski fakultet (Beograd)

1999-2010: Docent / Univerzitet u Beogradu - Hemijski fakultet (Beograd)

2010-2024: Vanredni profesor / Univerzitet u Beogradu - Hemijski fakultet (Beograd)

2024: Redovni profesor / Univerzitet u Beogradu - Hemijski fakultet (Beograd)

Oblasti naučnog interesovanja

Medicinska hemija - sinteza i ispitivanje dopaminergičke i serotonergičke aktivnosti sintetisanih liganada i kompjutersko modelovanje interakcija ligand-receptor

Ostale aktivnosti

Član Srpskog hemijskog društva od 1. 1. 1989. - Sekcija za medicinsku hemiju; Sekcija za organsku hemiju.

Prodekan za finansije Hemijskog fakulteta od 19. 5. 2007. do 19. 5. 2010.

Predsednik Komisije za disciplinsku odgovornost studenata od 12. 7. 2021.

Zamenik predsednika Etičke komisije od 9. 11. 2023.

Angažman u nastavi

Učešće u naučnoistraživačkim projektima

Završeni projekti:

  • 2011: Proučavanje odnosa strukture i aktivnosti novosintetisanih biološki aktivnih supstanci – 172032
    vrsta projekta:   domaći fundamentalni
    projekat finansira:   Ministarstvo za nauku i tehnološki razvoj Republike Srbije (Beograd)

Brojevi za identifikaciju autora

Izabrane reference

Knjige i revijalni radovi / Books and reviews:

  1. Prof. dr Danica Katanić, doc. dr Deana Dragović, asis. mr Iris Đorđević: Praktikum iz hemije sa računskim zadacima/Fakultet veterinarske medicine, Univerzitet u Beogradu, Beograd 1999./
  2. Dr Deana Andrić, dr Goran Roglić: Radni listovi iz organske hemije/Hemijski fakultet Univerzitet u Beogradu, Beograd 2010./
  3. Deana B. Andrić, Vladimir B. Šukalović: Piperazin - magičan molekul/Univerzitet u Beogradu - Hemijski fakultet , Beograd 2024./

Izabrani radovi / Selected papers:

  1. Roglić, Goran; Andrić, Deana; Kostić-Rajačić, Slađana; Dukić, Slađana; Šoškić, Vukić: Introduction of a methyl group in α- or β- position of 1-heteroarylethyl-4-phenylpiperazines affects their dopaminergic/serotonergic properties. Arch. Pharm. (2001), 334, 373-378.
  2. Roglić Goran; Dukić-Stefanović, Slađana; Andrić, Deana; Kostić-Rajačić, Slađana; Šoškić, Vukić: Investigation of mixed D2/5-HT1A activity of N-heteroarylmethyl-N-phenylpiperazines, N-heteroarylethyl-N-phenylpiperazines and N-heteroarylpropyl-N-phenylpiperazines. Pharmazie (2001), 56, 803-807.
  3. Šukalović, Vladimir; Roglić, Goran; Husinec, Suren; Kostić-Rajačić, Slađana; Andrić, Deana; Šoškić, Vukić: D2 dopaminergic 5HT1A serotonergic activity of 2-(1-naphtyl)ethyl- and 2-(2-naphtyl)ethyl amines. Arch. Pharm. (2003), 336, 514-522.
  4. Tomić, Mirko; Kundaković, Marija; Butorović, Biljana; Vasilev, Vesna; Dragović, Deana; Roglić, Goran; Ignjatović, Đurđica; Šoškić, Vukić; Kostić-Rajačić, Slađana: Pharmacological evaluation of 5-(2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl)-1,3-dihydro-benzimidazole-2-thione as a potential atypical antipsychotic agent. Pharmazie (2003), 58, 677-678.
  5. Šukalović, Vladimir; Andrić, Deana; Kostić Rajačić, Slađana; Roglić Goran; Šoškić, Vukić: Electrostatic surface potential calculation on several new halogenated benzimidazole-like dopaminergic ligands. Arch. Pharm. (2004), 337, 376-382.
  6. Šukalović, Vladimir; Zlatović Mario; Andrić, Deana; Kostić-Rajačić, Slađana; Roglić, Goran; Šoškić, Vukić: Modeling of the D2 dopamine receptor arylpiperazine binding site for 1-(2-[5-(1/H/-benzimidazole-2-thione)]ethyl)-4-arylpiperazines. Arch. Pharm. (2004), 337, 502-512.
  7. Veličković, Jelena; Andrić, Deana; Roglić, Goran; Tešić, Živoslav; Milojković-Opsenica, Dušanka: Planar chromatography of some 1-arylpiperazines behaving as dopaminergic ligands. JPC-J. Planar. Chromat. (2004), 17, 255-260.
  8. Tomić, Mirko; Kundaković, Marija; Butorović, Biljana; Janać, Branka; Andrić, Deana; Roglić, Goran; Ignjatović, Đurđica; Kostić-Rajačić, Slađana: Pharmacological evaluation of selected arylpiperazines with atypicalantipsychotic potential. Bioorg. Med. Chem. Lett. (2004), 14, 4263-4266.
  9. Šukalović, Vladimir; Andrić, Deana; Roglić, Goran; Kostić-Rajačić, Slađana; Schrattenholz, Andreas; Šoškić, Vukić: Synthesis, dopamine D2 receptor binding studies and docking analysis of 5-3-(4-arylpiperazin-1-yl)propyl-1H-benzimidazole, 5-2-(4-arylpiperazin-1-yl)ethoxy-1H-benzimidazole and their analogues. Eur. J. Med. Chem. (2005), 40, 481-493.
  10. Šukalović, Vladimir; Zlatović Mario; Andrić, Deana; Roglić, Goran; Kostić-Rajačić, Slađana; Šoškić, Vukić: Interaction of arylpiperazines with the D2 dopamine receptor binding site. Arzneimittel-Forsch./Drug Res. (2005), 55, 145-152.
  11. Zlatović Mario; Šukalović, Vladimir; Kostić-Rajačić, Slađana; Andrić, Deana; Roglić, Goran: Influence of N-1 substituent properties on binding affinities of arylpiperazines to the binding site of 5-HT1A receptor. J.Serb.Chem.Soc. (2006), 71(11), 1125-1135.
  12. Andrić, Deana; Tovilović, Gordana; Roglić, Goran; Vasković, Đurđica; Šoškić, Vukić; Tomić, Mirko; Kostić-Rajačić, Slađana: Synthesis and pharmacological evaluation of several N-(2-nitrophenyl)piperazine derivatives. J.Serb.Chem.Soc. (2007),72(5), 429-435.
  13. Andrić, Deana; Tovilović, Gordana; Roglić, Goran; Šoškić, Vukić, Tomić, Mirko; Kostić-Rajačić, Slađana: 6-[2-(4-Arylpiperazin-1-yl)ethyl]-4-halo-1,3-dihydro-2H-benzimidazole-2-thiones: synthesis and pharmacological evaluation. J.Serb.Chem.Soc. (2007), 72(8-9), 747-755.
  14. Penjišević, Jelena; Šukalović, Vladimir; Andrić, Deana; Kostić-Rajačić, Slađana; Šoškić, Vukić; Roglić, Goran: 1-Cinnamyl-4-(2-methoxyphenyl)piperazines: synthesis, binding properties, and docking to dopamine (D2) and serotonin (5-HT1A) receptors. Arch. Pharm. Chem. Life Sci. (2007), 340, 456-465.
  15. Tomić, Mirko; Ignjatović, Đurđica; Tovilović, Gordana; Andrić, Deana; Roglić, Goran; Kostić-Rajačić, Slađana: Two new phenylpiperazines with atypical antipsychotic potential. Bioorg. Med. Chem. Lett. (2007), 17, 5749-5753.
  16. Andrić, Deana; Roglić, Goran; Šukalović, Vladimir; Šoškić, Vukić; Kostić-Rajačić, Slađana: Synthesis, binding properties and receptor docking of 4-halo-6-[2-(4-arylpiperazin-1-yl)ethyl]-1H-benzimidazoles, mixed ligands of D2- and 5-HT1A receptors. Eur. J. Med. Chem. (2008), 43, 1696-1705.
  17. Šukalović, Vladimir; Zlatović, Mario; Roglić, Goran; Kostić-Rajačić, Slađana; Andrić, Deana: Application of hybrid density functional theory in calculation edge-to-face interactions of receptor-ligand system. Acta. Chim. Slov. (2009), 56, 270-277.
  18. Trfković, Jelena; Andrić, Filip; Ristivojević, P.; Andrić, Deana; Tešić, Živoslav; Milojković-Opsenica, Dušanka: Structure-retention relationship studz of arylpiperazines by linear multivariate modeling. J. Sep. Sci. (2010), 33, 2619-2628.
  19. Tomić, Mirko; Vasković, Đurđica; Tovilović, Gordana; Andrić, Deana; Penjišević, Jelena; Kostić-Rajačić, Slađana: Pharmacological evaluation of halogenated and non-halogenated arylpiperazin-1-yl-ethyl-benzimidazoles as D2 and 5-HT2A receptor ligands. Arch. Pharm. Chem. Life Sci. (2011), 344(5), 287-291.
  20. Senćanski, Milan; Šukalović, Vladimir; Došen-Mićović, Ljiljana; Šoškić, Vukić; Andrić, Deana; Roglić, Goran; Kostić-Rajačić, Slađana: Modeling interactions of alpha (1a) adenergic receptor and different arylpiperazine ligands. Dig. J. Nanomater. Bios. (2012), 7(4), 1767-1777.
  21. Šukalović, Vladimir; Ignjatović, Đurđica; Tovilović, Gordana; Andrić, Deana; Shakib, K.; Kostić-Rajačić, Slađana; Vukić, Šoškić: Interactions of N-{[2-(4-phenyl-piperazin-1-yl)-ethyl]-phenyl}-2-aryl-2-yl-acetamides and 1-{[2-(4-phenyl-piperazin-1-yl)-ethyl]-phenyl}-3-aryl-2-yl-ureas with dopamine D2 and 5-hydroxyltryptamine 5HT1A receptors. Bioorg. Med. Chem. Lett. (2012), 22(12), 3967-3972.
  22. Ignjatović, Đurđica; Vojnović Milutinović, D.; Nikolić-Kokić, A.; Slavić, M.; Andrić, Deana; Tomić, Mirko; Kostić-Rajačić, Slađana: The mechanisms responsible for neuroprotective capacity of arylpiperazine dopaminergic ligands against cell death induced by sodium nitroprusside. Eur. J. Pharmacol. (2012), 683, 93-100.
  23. Šulalović, Vladimir; Šoškić, Vukić; Andrić, Deana, Roglić, Goran; Kostić-Rajačić, Slađana: Modeling key interactions between dopamine D2 receptor second extracellular loop and arylpiperazine ligands. J. Serb. Chem. Soc. (2012), 77(3), 259-277.
  24. Novaković, Irena; Penjišević, Jelena; Šukalović, Vladimir; Andrić, Deana; Roglić, Goran; Kostić-Rajačić, Slađana: Investigation of antibacterial activity of cinnamyl derivates of arylpiperazine. Arch. Biol. Sci. (2012), 64(1), 15-20.
  25. Šukalović, Vladimir; Bogdan, A.E.; Tovilović, Gordana; Ignjatović, Đurđica; Andrić, Deana; Kostić-Rajačić, Slađana; Šoškić, Vukić: N-{[2-(4-Phenyl-piperazin-1-yl)-ethyl]-phenyl}-arylamides with dopamine D2 and 5-hydroxytryptamine 5HT1A activity: synthesis, testing and molecular modeling. Arch. Pharm. Chem. Life Sci. (2013), 346, 708-717.
  26. Šukalović, Vladimir; Šiškić, Vukić; Senćanski, Milan; Andrić, Deana; Kostić-Rajačić, Slađana: Determination of key receptor-ligand interactions of dopaminergic arylpiperazines and the dopamine D2 receptor homology model. J. Mol. Model. (2013), 19(4), 1751-1762.
  27. Vasić, Vesna; Penjišević, Jelena; Novaković, Irena; Šukalović, Vladimir; Andrić, Deana; Kostić-Rajačić, Slađana: Synthesis and biological evaluation of 5-substituted derivatives of benzimidazole. J. Serb. Chem. Soc. (2014), 79(3), 277-282.
  28. Šukalović, Vladimir; Šoškić, Vukić; Ignjatović, Đurđica; Andrić, Deana; Penjišević, Jelena; Kostić-Rajačić, Slađana: Investigation of key interactions between the second extracellular loop of the dopamine D2 receptor and several hydroxy-N-{[2-(4-phenylpiperazin-1-yl)ethyl]phenyl}-nicotinamides. J. Serb. Chem. Soc. (2014), 79(12), 1461-1467.
  29. Penjišević, Jelena; Šukalović, Vladimir; Andrić, Deana; Roglić, Goran; Šoškić, Vukić; Kostić-Rajačić, Slađana: Synthesis, biological, and Computational evaluation of substituted 1-(2-methoxyphenyl)-4-(1-phenethylpiperidin-4-yl)piperazines and 1-(2-methoxyphenyl)-4-[(1-phenethylpiperidin-4-yl)methyl]piperazines as dopaminergic ligands. Arch. Pharm. Chem. Life Sci. (2016), 349, 614-626.
  30. Kostić-Rajačić, Slađana; Schwall, Gerhart; Penjišević, Jelena; Andrić, Deana; Šukalović, Vladimir;  Šoškić, Vukić: Identification of NQO1 and ferrochelatase as interaction partners for neuroprotective N-{[2-(4-phenylpiperazin-1-yl)ethyl]phenyl}arylamides. Chem. Biol. Drug Des. (2018), 91(1), 1393-1397.
  31. Šegan, Sandra; Penjišević, Jelena; Šukalović, Vladimir; Andrić, Deana; MIlojković-Opsenica, Dušanka: Investigation of lipophilicity and pharmacokinetic properties of 2-(methoxyphe nyl)piperazine dopamine D2 ligands. J. Chromatogr. B (2019), 1124, 146-153.
  32. Jevtić, Ivana; Lai, Hang; Penjišević, Jelena; Dukić-Stefanović, Slađana; Andrić, Deana; Burst, Peter; Kostić-Rajačić, Slađana; Teodoro, Rodrigo: Newly synthesized fluorinated cinnamylpiperazines possessing low in vitro MAO-B binding. Molecules (2020), 25(21), 4941.
  33. Dukić-Stefanović, Slađana; Lai, Hang; Toussaint, Magali; Claus, Oliver; Jevtić, Ivana; Penjišević, Jelena; Andrić, Deana; Ludwig, Freidrich-Alexander; Gundel, Daniel; Deuther-Conrad, Winnie; Kostić-Rajačić, Slađana; Burst, Peter; Teodoro, Rodrigo: In vitro and in vivo evaluation of fluorinated indanone derivatives as potential positron emission tomography agents for the imaging of monoamine oxidase B in the brain. Bioorg. Med. Chem. Lett. (2021), 48, 128254.
  34. Penjišević, Jelena; Šukalović, Vladimir; Andrić, Deana; Suručić, Relja; Kostić-Rajačić, Slađana: The therapeutic potential of 2-{[4-(2-methoxyphenyl)piperazin-1-yl]alkyl}-1H-benzo[d]imi dazoles as ligands for alpha1-adrenergic receptor-comparative in silico and in vitro study. App. Biochem. Biotechnol. (2022), 194(8), 3749-3764.
  35. Penjišević, Jelena; Šukalović, Vladimir; Dukić-Stefanović, Slađana; Deuther-Conrad, Winnie; Andrić, Deana; Kostić-Rajačić, Slađana: Synthesis of novel 5-HT1A arylpiperazine ligands: binding data and computer-aided analysis of pharmacological potency. Arab. J. Chem. (2023), 16, 104636.
  36. Jevtić, Ivana; Suručić, Relja; Tovilović, Gordana; Zogović, Nevena; Kostić, Rajačić, Slađana; Andrić, Deana; Penjišević, Jelena: Multi-Target potential of newly designed tacrine-derived choline sterase inhibitors: synthesis, computational and pharmacological study. Bioorg. Med. Chem. (2024) 101, 117649.